Business Strategy for Pharmaceuticals/Drugs in Japan

The market for pharmaceuticals/drugs in Japan is approximately $60 billion.

Western pharmaceutical/drug companies are using multiple business strategies in Japan today. While a number of foreign manufacturers are selling or planning to sell their drugs and pharmaceuticals in Japan, others are sourcing/manufacturing, doing R+D, and performing clinical trials. Should a foreign drug company set up a representative office, branch office, joint venture, or a KK office in Japan today?

Let PBM help you with your Japan pharmaceutical business strategy.

PBM will study the various opportunities for your pharmaceutical/drug products and come up with the best strategy for you.

For more information on developing your Japan business strategy, please see the following PBM publications and/or contact us to discuss your specific needs.

Contract Research Organizations in Asia 2011 (publication for sale)
Orphan Drugs in Asia: Guidelines and Regulatory Requirements 2011 (publication for sale)
Foreign Manufacturer Accreditation for Drugs in Japan (webcast for sale)
Doing Business in Japan (webcast for sale)
Managing Asian Cultural Diversity: Cross-Cultural Issues in Asia (webcast for sale)
Strategies for Success in China, Japan, and India (webcast for sale)
How To Do Business in Japan (PDF)
Marketing and Distributing Medical Products in Japan